In this Phase I Cutting-Edge Basic Research Awards (CEBRA) application, a proof-of-concept study to examine effects of treatment with d-cycloserine for facilitating extinction of craving provoked by repeated exposure to cigarette smoking cues is proposed. Smoking cues will be presented using an established virtual reality simulator. The benefits of this treatment approach together with cognitive behavioral treatment for reducing cigarette smoking will then be determined. The project's specific aims are to determine the effects of four weeks of once-weekly treatment with d-cycloserine or placebo on craving elicited by exposure to """"""""virtual reality"""""""" smoking cues and then to determine the effects of this combined with cognitive behavioral treatment on frequency of cigarette smoking. Participants will receive smoking cessation treatment consisting of an orientation session followed by four weekly sessions consisting of 20 minutes of cognitive behavioral treatment followed by 35 min of exposure to smoking cues. Brief cognitive behavioral treatment is provided in addition to the virtual reality cue exposure in order to help participants cope with cigarette craving elicited by exposure to smoking cues. The project's primary hypothesis is that treatment with d-cycloserine prior to each exposure session will be associated with greater extinction of craving and that this together with cognitive behavioral treatment will be associated with reductions in cigarette smoking. In this Phase I Cutting-Edge Basic Research Awards (CEBRA) application, a proof-of-concept study to examine effects of treatment with d-cycloserine for facilitating extinction of craving provoked by exposure to cigarette smoking cues is proposed. This project may lead to the development of new treatment approaches for addictions. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Exploratory/Developmental Grants (R21)
Project #
5R21DA023588-03
Application #
7495052
Study Section
Special Emphasis Panel (ZDA1-MXS-M (01))
Program Officer
Wetherington, Cora Lee
Project Start
2007-09-15
Project End
2010-08-31
Budget Start
2008-09-01
Budget End
2010-08-31
Support Year
3
Fiscal Year
2008
Total Cost
$150,920
Indirect Cost
Name
Baylor College of Medicine
Department
Psychiatry
Type
Schools of Medicine
DUNS #
051113330
City
Houston
State
TX
Country
United States
Zip Code
77030
Mahoney, James J; Kalechstein, Ari D; De Marco, Anthony P et al. (2017) The relationship between premorbid IQ and neurocognitive functioning in individuals with cocaine use disorders. Neuropsychology 31:311-318
Yoon, Jin H; Newton, Thomas F; Haile, Colin N et al. (2013) Effects of D-cycloserine on cue-induced craving and cigarette smoking among concurrent cocaine- and nicotine-dependent volunteers. Addict Behav 38:1518-26
Kalechstein, A D; Yoon, J H; Mahoney 3rd, J J et al. (2012) d-Cycloserine administration does not affect neurocognition in concurrent cocaine- and nicotine-dependent volunteers. Pharmacol Biochem Behav 103:403-7